📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children. (2016)

First Author: Garcia-Prats AJ

Attributed to: A phase III cluster randomised placebo-controlled trial to assess the efficacy of preventive therapy in child and adolescent contacts of MDR-TB funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5588/ijtld.16.0293

PubMed Identifier: 27776587

Publication URI: http://europepmc.org/abstract/MED/27776587

Type: Journal Article/Review

Volume: 20

Parent Publication: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Issue: 11

ISSN: 1027-3719